Improved bioavailability through floating microspheres of lovastatin

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 1, 2011, Pages 57-64

  Kumar, S ^a   Nagpal, K ^b   Singh, SK ^b   Mishra, DN ^b  

^a Hindu College   (India)

^b GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Floating drug delivery system; In vitro drug release; Microsphere

Indexed keywords

BETA CYCLODEXTRIN; CHOLESTEROL; ETHYL CELLULOSE; METHYLCELLULOSE; MEVINOLIN; MICROSPHERE; POLYMER; SOLVENT;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFUSION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; EMULSION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; RAT; TABLET FORMULATION;

EID: 79953268965     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharma Sei. 1992; 81: 135-140.
2. Burgass DJ, Hickey, AJ, Swarbrick J, Boylan JC. Microsphere process and Technology. In: Swarbrick J, Boylan JC, ed. Encyclopedia of Pharmaceutical Technology, New York: Marcel Dekker; 1995; 1-29.
3. Sugao H, Yamazaki S, Shiozawa H, Yano K. Taste masking of nitter drug powder without loss of bioavailability by heat treatment of wax coated microspheres, J. Pharm. Sei. 1998; 87: 96-100.
4. Orienti I, Aiedeh K, Gianasi E, Bertasi V, Zecchi V, Indomethacin loaded chitosan microspheres:Correlation between erosion process and release kinetics, J. Microencapsul. 1996; 13: 463-472.
5. Chickering DE 3rd, Harris WP, Mathiowitz E, A microtensinometer for the analysis of bioadhesive microspheres, Biomed instrum Technol. 1995; 29: 501-512.
6. Bjork, E, Edman P, Degradable starch microspheres as a nasal delivery system for insulin, Int. J. Pharm. 1988;47:233-238.
7. Thanoo BC, Jayakrishnan A, Radioopaque hydrogel microspheres, J. Microencapsulation. 1989; 16: 233-244.
8. Polard E, Lecorre P, Chevanne F, and Le Verage R, Invitro and in vivo evaluation of polylactide and polylactide-coglycoside microspheres of morphine for site specific delivery, Int. J. Pharm. 1996; 134: 37-46.
9. USP28-NF23 Page 1156. Pharmacopeial Forum: Volume No. 29 (5) page 1525.
10. Joseph NJ, Laxmi S, Jayakrishan A, A floating type oral dosage from for piroxicam based on hollow microspheres: in vitro and in vivo evaluation in rabbits, J Control Release. 2002; 79: 71-79.
11. Yang L, Fassihi R, Zero order release kinetics from self correcting floatable configuration drug delivery system, J Pharm Sei. 1996; 85:170-173.
12. Fell John T, Whitehead L, Collet JH, Prolonged gastric retention using floating dosage forms, Pharm Tech. 2000; 3: 82-90.
13. Whitehead L, Collett JH, Fell JT, Amoxycillin release from a floating dosage form based on alginates, Int J Pharm 2000; 210:45-49.
14. Hilton AK, Deasy PB, In vitro and in vivo evaluation of an oral sustained release floating dosage form of amoxycillin trihydrate. Int J Pharm. 1992; 86:79-88.
15. Patel JK, Patel RP, Amin AF, Patel MM, Formulation and Evaluation of Mucoadhesive Glipizide Microspheres, AAPS PharmSciTech. 2005; 6: E49-55.
16. Meyer BJ, Hammervold T, Rustan AC, Howe PR, Dose-Dependent Effects of Docosahexaenoic Acid Supplementation on Blood Lipids in Statin-Treated Hyperlipidaemic Subjects, Lipids. 2007; 42:109-115.
17. Mehramizi A, Asgari ME, Pourfarzib M, Bayati Kh, Dorkoosh FA, Rafiee-Tehrani M, Influence of ß - cyclodextrin complexation on lovastatin release from osmotic pump tablets (OPT), DARU. 2007; 15: 71-78.